Page last updated: 2024-10-30

ly 303511 and Benign Neoplasms

ly 303511 has been researched along with Benign Neoplasms in 1 studies

LY 303511: inhibitor of phosphatidylinositol 3-kinase

Research Excerpts

ExcerptRelevanceReference
"The metastasis suppressor breast cancer metastasis suppressor 1 (BRMS1) upregulates GJIC and decreases phosphoinositide-3-kinase (PI3K) signaling."1.36Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition. ( Beck, BH; Bodenstine, TM; Cook, LM; Diers, AR; Ismail, A; Landar, A; Vaidya, KS; Welch, DR, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bodenstine, TM1
Vaidya, KS1
Ismail, A1
Beck, BH1
Cook, LM1
Diers, AR1
Landar, A1
Welch, DR1

Other Studies

1 other study available for ly 303511 and Benign Neoplasms

ArticleYear
Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition.
    Cancer research, 2010, Dec-01, Volume: 70, Issue:23

    Topics: Androstadienes; Cell Communication; Cell Line, Tumor; Cell Membrane; Chromones; Connexin 43; Cyclic

2010